Jackaldu / iStock
California-based healthcare company NantHealth has appointed Sandeep Reddy as chief medical officer.
In his new position, Dr. Reddy will be responsible for overseeing education, outreach, clinical development programs, and clinical trials for GPS Cancer, a comprehensive, molecular profile and NantHealth's proprietary revolutionary pan-omic cancer analytic platform.
“Appointing Dr. Reddy and his experience to our leadership team will be highly valuable to the evolution of the GPS Cancer initiative,” said Dr. Patrick Soon-Shiong, founder and CEO of NantHealth. “With extensive background in hematology, medical oncology and therapeutics research, Dr. Reddy will play a key role in helping NantHealth achieve victory in the war against cancer.”
Dr. Reddy added: “The milestones that NantHealth has achieved in just over a year have established the company as a proven disrupter – national and international insurance coverage of the GPS Cancer profile, multiple partnerships with leading medical institutions and joining experts in the cancer community are immense efforts to take on and in such a condensed timeframe. I’m thrilled to be a part of an initiative that has potential to change the way we approach and treat cancer."
NantHealth, Appointment, Sandeep Reddy, Cancer, California, US
